Unselective binding of target cells thus represents a major drawback of this cytotherapy model since the occurrence of liver as well as of other parenchymal damage has already been reported in preliminary studies by Kim et al. [16] when treating glioma in mice with TRAIL-transduced UC-MSCs. The gene discussed is TNFSF10; the disease is central nervous system cancer.